Free Trial

Health Catalyst Q1 2023 Earnings Report

Health Catalyst logo
$7.09 +0.12 (+1.72%)
(As of 12/20/2024 05:31 PM ET)

Health Catalyst Earnings Headlines

We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Health Catalyst (HCAT) Receives a Buy from J.P. Morgan
Health Catalyst price target raised to $9 from $7 at Stephens
See More Health Catalyst Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Health Catalyst? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Health Catalyst and other key companies, straight to your email.

About Health Catalyst

Health Catalyst (NASDAQ:HCAT) provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

View Health Catalyst Profile

More Earnings Resources from MarketBeat

Upcoming Earnings